Mereo BioPharma Group plc SEC filings MREO
Mereo BioPharma Group plc has 439 filings in SEC EDGAR's recent list, going back to Dec 1, 2017. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 2, 2026 | — |
| S-8 | Employee stock plan registration | Jan 23, 2025 | — |
| 424B3 | Prospectus | Dec 4, 2024 | — |
| S-3 | Shelf registration | Nov 25, 2024 | — |
| 424B5 | Prospectus supplement | Jun 14, 2024 | — |
| S-3 | Shelf registration | May 15, 2024 | — |
| S-8 | Employee stock plan registration | Jan 23, 2024 | — |
| S-8 | Employee stock plan registration | Jan 24, 2023 | — |
| S-8 | Employee stock plan registration | Jan 13, 2022 | — |
| F-3/A | Filing | Sep 27, 2021 | — |
| F-3/A | Filing | Sep 7, 2021 | — |
| F-6EF | Filing | Aug 13, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 5, 2021 | — |
| 424B5 | Prospectus supplement | Feb 10, 2021 | — |
| 424B5 | Prospectus supplement | Feb 9, 2021 | — |
| S-8 | Employee stock plan registration | Jan 15, 2021 | — |
| 424B5 | Prospectus supplement | Oct 23, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 6, 2020 | — |
| F-6EF | Filing | Oct 6, 2020 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 6, 2020 | — |
| POS AM | Filing | Jul 2, 2020 | — |
| F-1/A | Filing | Mar 12, 2020 | — |
| F-1/A | Filing | Mar 6, 2020 | — |
| S-8 | Employee stock plan registration | Feb 18, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Feb 18, 2020 | — |
| S-8 | Employee stock plan registration | May 21, 2019 | — |
| 424B3 | Prospectus | Mar 20, 2019 | — |
| F-4/A | Filing | Mar 15, 2019 | — |
| F-6/A | Filing | Jan 25, 2019 | — |
| F-4 | Filing | Jan 25, 2019 | — |
| F-6/A | Filing | Apr 9, 2018 | — |
| F-1/A | Amendment no.1 to form f-1 | Apr 9, 2018 | — |
| F-6 | Filing | Mar 23, 2018 | — |
| F-1 | Registration statement (foreign issuer) | Mar 23, 2018 | — |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MREO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1719714
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.